HealthEquity, Inc. Website

HealthEquity, Inc.

NasdaqGS-HQY

Company Overview

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

  • Name

    HealthEquity, Inc.

  • CEO

    Scott R. Cutler

  • Website

    www.healthequity.com

  • Sector

    Health Care Providers and Services

  • Year Founded

    2002

Company Statistics

Profile

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    —

  • Employees

    —

Margins

  • Gross

    —

  • EBITDA

    —

  • Operating

    —

  • Pre-Tax

    —

  • Net

    —

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    —

  • ROTA

    —

  • ROE

    —

  • ROCE

    —

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    —

  • Net Debt

    —

  • Debt/Equity

    —

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    —

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

What's happening

Nov 12, 2025 - Dec 12, 2025

Healthequity Inc Faces Market Challenges Amid Mixed Earnings Report

  • Healthequity Inc reported third-quarter earnings that exceeded EPS expectations but fell short on net income.
  • Analyst optimism was evident with upgrades from Deutsche Bank and Barclays following the earnings report.
  • Despite positive analyst sentiment, bearish trends persisted due to ongoing concerns about long-term shareholder satisfaction.

Over the past month, Healthequity Inc (HQY) experienced a decline of 4.1%, significantly underperforming the S&P 500, which returned 0.7% during the same period. This resulted in an underperformance of -4.8% relative to the S&P 500 and reflected broader challenges faced by HQY in navigating market sentiment and investor expectations. The stock exhibited notable fluctuations influenced by various analyst ratings and earnings reports, contributing to its overall downward trajectory.

On December 4th, HQY reported third-quarter financial results that initially sparked positive reactions in the market; however, mixed sentiments emerged afterward. The company exceeded earnings expectations with an adjusted EPS of $1.01 against an estimate of $0.93 while reporting revenue growth of 7% year-over-year at $322.2 million—slightly surpassing forecasts as well. Nonetheless, net income fell short at $51.7 million and pretax profit was below projections at $67.5 million.

In subsequent days following this report from December 5th through December 8th, analysts expressed optimism regarding HQY's future performance despite earlier bearish trends impacting share prices ahead of earnings announcements on December 3rd and again just before reporting results on December 2nd when negative signals were noted concerning long-term shareholder satisfaction amid declining stock prices over the previous year—a situation exacerbated by lower gross profit margins compared to peers within the sector.

Overall performance metrics indicate that Healthequity Inc underperformed not only relative to broader market indices but also specifically within its sector; it lagged behind Health Care (XLV), which itself showed a decline of -6%. These factors combined highlight significant volatility for HQY amidst fluctuating analyst opinions and evolving investor sentiments throughout this one-month period.

NasdaqGS:HQY